With the aim of making people learn more about Alzheimer’s disease, Prof. Tengfei Guo gave an inspirational lecture about the early diagnosis and treatment of Alzheimer’s disease to the members of Shenzhen Bay laboratory on June 25th.
This report introduced the application and current status of technologies such as PET imaging and CSF/Plasma biomarkers in the early diagnosis of AD. Amyloid plaques and neurofibrillary tau tangles are the two main pathological features of AD, and they are also the basis for distinguishing AD dementia from non-AD dementia. Studies have shown that abnormal changes in Aβ and tau can be reflected in CSF (cerebrospinal fluid), Plasma biomarkers and PET imaging 15-20 years before the earliest clinical symptoms of AD appear.
In addition, this report also introduces the latest developments of drug and non-drug treatments related to AD.
The lecture ended in a burst of applause. In the future, Prof. Guo Tengfei will hold more exciting lectures to make people learn more about Alzheimer's disease.